These Analysts Boost Their Forecasts On Salesforce Following Strong Q2 Results

Salesforce beat Q2 results, posting revenue of $11.35B vs $11.32B consensus and adjusted EPS of $5.90 vs $3.27 expected. The company raised FY27 revenue guidance to $46.1B–$46.4B (from $45.9B–$46.2B) and lifted adjusted EPS to $16.67–$16.71 (from $14.06–$14.12), well above the $14.14 consensus estimate. Shares jumped 11.2% pre-market to $228.55 as analysts upgraded/raised targets and management pointed to strong AI-driven demand with ARR nearing $4B.

Analysis

The key implication is not the beat itself but the signal that CRM is getting operating leverage without needing a top-line re-acceleration. That matters for the entire large-cap SaaS complex: if the market believes AI attach can raise ARPU and improve productivity at the same time, capital will rotate toward platform vendors with installed bases and away from point solutions that rely on seat expansion. The most obvious second-order loser is the long tail of narrower workflow/cloud software names whose pricing power weakens if enterprise buyers consolidate spend into fewer suites.

The move is likely to be partly a positioning squeeze in a crowded, under-owned software name, so the first 1-3 days are more about flows than fundamentals. The next real catalyst is whether the company can convert the AI narrative into a better billings/RPO trajectory over the next 1-2 quarters; without that, the market will eventually treat this as a margin beat and multiple re-rating rather than a durable growth inflection. If macro softens and IT budgets tighten, the upside thesis becomes more fragile because AI enthusiasm cannot fully offset slower new-logo and expansion demand.

Contrarian risk: consensus may be underestimating how much of the guidance raise is coming from cost discipline and buybacks rather than durable demand acceleration. If AI monetization is mostly bundled into existing contracts, the incremental revenue may disappoint versus the rhetoric, which would cap further upside once the gap move is digested. The thesis is falsified if next-quarter cRPO/billings growth stalls or if management stops seeing AI-driven attach rates convert into measurable net retention improvement.

Key Decisions for Investors

• Buy CRM on a 3-5% intraday or post-open pullback; risk/reward is best only if the gap holds, with upside to a higher multiple if AI attach shows up in the next two quarters.
• Pair trade: long CRM / short an enterprise software basket (IGV or a smaller-point-solution proxy such as WDAY) for 1-3 months; CRM has clearer balance-sheet and installed-base leverage if buyers consolidate around platform vendors.
• Do not chase CRM after an 11% pre-market gap unless the stock closes above the opening range; otherwise expect a fade as the move gets digested by profit-takers.
• Set a watch item on CRM's next billings, cRPO, and AI ARR commentary; if those do not inflect, trim longs and treat this as a multiple event rather than a new growth leg.
• If you want convex exposure, use a call spread rather than stock only if implied vol is still reasonable after the open; the trade only works if the market keeps paying for AI monetization optionality.